Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerPolicy UpdatesOtorhinolaryngology (ENT)Colorado Rocky Mountain Nasal Policy Update | Open…
    Ask Trek AI about this page
    ModifiedColorado Rocky Mountain Health PlansPolicy SRST.MP.019.36

    Rhinoplasty and Other Nasal Procedures

    Customize your policy alerts

    Sign up for Colorado Rocky Mountain Health Plans Policy SRST.MP.019.36 alerts

    Get alerted when Policy SRST.MP.019.36 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage and medical necessity for nasal valve procedures, rhinoplasty, nasal polypectomy, and selected nasal nerve or radiofrequency procedures. It applies to providers treating members under the applicable benefit plan, with reconstructive coverage limited to documented functional impairment and specified clinical criteria.

    Policy Summary
    PayerColorado Rocky Mountain Health Plans
    PolicyRhinoplasty and Other Nasal Procedures
    Policy CodePolicy SRST.MP.019.36
    Change TypeModified
    Effective DateNovember 1, 2026
    Next Review DateN/A
    Key ActionDocument the qualifying indication, examination findings, photographs, treatment plan, and required conservative-management history before submitting reconstructive rhinoplasty or nasal valve procedures.
    SourceLink
    POLICY UPDATE CHANGES

    The policy added language stating that absorbable polylactic acid nasal cartilage support implants, such as the Latera Absorbable Nasal Implant, are unproven and not medically necessary.

    The policy added language stating that posterior nasal nerve or sphenopalatine ganglion ablation by any method, including radiofrequency or cryoablation, is unproven and not medically necessary for chronic rhinitis.

    The policy added language stating that radiofrequency treatment of the nasal valves for nasal airway obstruction, such as the VivAer ARC Stylus, is unproven and not medically necessary.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    3Unproven nasal procedure categories
    6 weeksPersistent obstruction after medical management
    4 weeksConservative management before qualifying rhinoplasty
    14Applicable procedure codes

    Covered and Noncovered Procedures

    Nasal valve procedures

    Covered as reconstructive and medically necessary when ALL criteria are met.

    Nasal valve procedure criteria

    • Clinical obstruction: Prolonged, persistent, obstructed nasal breathing due to internal and/or external nasal valve compromise
    • Other causes treated: Other causes of nasal obstruction, including rhinosinusitis, allergic rhinitis, vasomotor rhinitis, nasal polyposis, adenoid hypertrophy, and/or nasopharyngeal masses, have been adequately treated with maximal therapy and nasal obstruction persists
    • Septal/turbinate status: Nasal septal deviation and turbinate hypertrophy are not present, have been previously surgically treated, or are scheduled to be surgically treated at the same time as the nasal valve procedure as part of the surgery plan
    • Objective collapse: Visible collapse of the alar lower lateral cartilage and/or lateral nasal wall with deep inspiration is documented
    • Modified Cottle response: Subjective and audible improvement in nasal airflow occurs during the modified Cottle maneuver
    • Photographic confirmation: Photos document dynamic collapse or anatomical deformity narrowing the internal and/or external nasal valve as a main cause of mechanical nasal airway obstruction and are consistent with the clinical examination
    • Surgical characterization and plan: The surgeon states whether compromise is static or dynamic, identifies the internal valve, external valve, or both, and provides a clear surgical plan including the need for a cartilage graft

    Rhinoplasty for congenital anomalies

    Covered as reconstructive and medically necessary when associated with a qualifying congenital craniofacial anomaly.

    Congenital anomaly indications: Nasal deformity associated with a congenital craniofacial anomaly, including Pierre Robin syndrome, Apert syndrome, Fraser syndrome, Binder syndrome, Goldenhar syndrome, nasal dermoids, Tessier nasal cleft, or cleft lip or cleft palate

    Primary rhinoplasty

    Covered as reconstructive and medically necessary when ALL criteria are met.

    Primary rhinoplasty criteria

    • Qualifying indication: The indication is prolonged, persistent, obstructed nasal breathing due primarily to nasal bone and septal deviation; a nasal fracture with nasal bone displacement severe enough to cause nasal airway obstruction; or a residual large cutaneous defect following resection of a malignancy or nasal trauma
    • Septoplasty insufficient: The nasal airway obstruction cannot be corrected by septoplasty alone, as documented in the medical record
    • Photographic and examination evidence: Photos and clinical examination document nasal bone/septal deviation as the primary cause of mechanical nasal airway obstruction
    • Corrective surgical design:

    Revision rhinoplasty

    Covered as reconstructive and medically necessary when ALL criteria are met.

    Revision rhinoplasty criteria

    • Photographic and examination evidence: Photos and clinical examination document the secondary deformity or complication as the primary cause of mechanical nasal airway obstruction
    • Corrective surgical design: The proposed procedure is designed to correct the deformity or treat the complication and relieve the nasal airway obstruction
    • Significant symptoms: Nasal airway obstruction is causing significant symptoms, such as chronic rhinosinusitis or difficulty breathing
    • Conservative management failure: Obstructive symptoms persist despite conservative management, including nasal steroids or immunotherapy where appropriate

    Tip rhinoplasty

    Covered as reconstructive and medically necessary when ALL criteria are met.

    Tip rhinoplasty criteria

    • Photographic and examination evidence: Photos and clinical examination document tip drop as the primary cause of mechanical nasal airway obstruction, including documentation of the acute columellar-labial angle
    • Corrective surgical design: The proposed procedure is designed to correct the mechanical nasal airway obstruction by lifting the nasal tip
    • Significant symptoms: Nasal airway obstruction is causing significant symptoms, such as chronic rhinosinusitis or difficulty breathing
    • Conservative management failure: Obstructive symptoms persist despite conservative management, including nasal steroids or immunotherapy where appropriate

    Nasal polypectomy

    Coverage criteria are directed to InterQual.

    Nasal polypectomy is considered reconstructive and medically necessary in certain circumstances; apply the InterQual CP: Procedures, Polypectomy, Nasal clinical coverage criteria

    Unproven and not medically necessary procedures

    Not medically necessary due to insufficient evidence of safety and/or efficacy.

    Unproven procedures: Absorbable polylactic acid nasal cartilage support implants; posterior nasal nerve or sphenopalatine ganglion ablation by any method, including radiofrequency or cryoablation, for treatment of chronic rhinitis; or radiofrequency treatment of the nasal valves for treatment of nasal airway obstruction

    Unproven and not medically necessary nasal procedures

    Each of the following procedure categories is considered unproven and not medically necessary due to insufficient evidence of safety and/or efficacy.

    Unproven nasal procedures

    • Absorbable nasal cartilage support implants: Absorbable polylactic acid nasal cartilage support implants, such as the Latera Absorbable Nasal Implant, used to support the nasal upper and lower lateral cartilage
    • Posterior nasal nerve or sphenopalatine ganglion ablation using any method, such as radiofrequency or cryoablation, including RhinAer or ClariFix, for treatment of chronic rhinitis
    • Radiofrequency treatment of nasal valves for treatment of nasal airway obstruction, such as the VivAer ARC Stylus

    The listed nasal procedures are considered reconstructive and medically necessary only when the applicable qualifying criteria are met. Outside those criteria—including indications that are primarily cosmetic or lack documented functional impairment—the procedures are not considered reconstructive and medically necessary.

    Absorbable polylactic acid nasal cartilage support implants, posterior nasal nerve or sphenopalatine ganglion ablation for chronic rhinitis, and radiofrequency treatment of the nasal valves for nasal airway obstruction are considered unproven and not medically necessary because of insufficient evidence of safety and/or efficacy.

    Adjunctive procedures involving the nasal septum, nasal valve, turbinates, or paranasal sinuses that are performed without affecting nasal shape or appearance do not meet the policy definition of rhinoplasty and are excluded from consideration under the rhinoplasty guideline.

    Absorbable polylactic acid nasal cartilage support implants, including the Latera Absorbable Nasal Implant, used to support the nasal upper or lower lateral cartilage are excluded from coverage as unproven and not medically necessary.

    Posterior nasal nerve or sphenopalatine ganglion ablation by any method, including radiofrequency or cryoablation, for treatment of chronic rhinitis is excluded from coverage as unproven and not medically necessary. Examples include RhinAer and ClariFix.

    Radiofrequency treatment of the nasal valves for nasal airway obstruction, including the VivAer ARC Stylus, is excluded from coverage as unproven and not medically necessary.

    Nasal valve procedures or repair of nasal vestibular stenosis or alar collapse are not medically necessary for indications outside the stated reconstructive criteria. Coverage requires documented functional obstruction and the applicable treatment, examination, photographic, and surgical-plan requirements.

    Primary rhinoplasty is not medically necessary for indications outside the qualifying criteria, including specified mechanical obstruction from nasal bone or septal deviation, sufficiently displaced nasal fracture, or a residual large cutaneous defect after malignancy resection or nasal trauma.

    Revision rhinoplasty is primarily cosmetic and is not medically necessary unless it treats a complication or residual deformity from primary surgery performed for functional impairment, with persistent documented functional impairment and fulfillment of the applicable obstruction, symptom, examination, treatment-plan, and 4 weeks or greater conservative-management requirements.

    Tip rhinoplasty is primarily cosmetic and is not medically necessary unless tip drop is the primary documented cause of mechanical nasal airway obstruction. The procedure must be intended to lift the nasal tip, with supporting examination and photographs, significant symptoms, and persistent symptoms despite conservative management for 4 weeks or greater.

    The specified absorbable nasal cartilage support implants, posterior nasal nerve or sphenopalatine ganglion ablation for chronic rhinitis, and radiofrequency nasal valve procedures for nasal airway obstruction are considered unproven and not medically necessary due to insufficient evidence of safety and/or efficacy.

    Under the current policy, absorbable polylactic acid nasal cartilage support implants such as Latera, posterior nasal nerve or sphenopalatine ganglion ablation by radiofrequency or cryoablation such as RhinAer or ClariFix, and radiofrequency nasal valve treatment such as VivAer ARC Stylus are excluded as unproven and not medically necessary.

    Applicable Codes and Clinical Thresholds

    Applicable CodesCPT
    30400Rhinoplasty, primary; lateral and alar cartilages and/or elevation of nasal tip
    30410Rhinoplasty, primary; complete, external parts including bony pyramid, lateral and alar cartilages, and/or elevation of nasal tip
    30420Rhinoplasty, primary; including major septal repair
    30430Rhinoplasty, secondary; minor revision (small amount of nasal tip work)
    30435Rhinoplasty, secondary; intermediate revision (bony work with osteotomies)
    30450Rhinoplasty, secondary; major revision (nasal tip work and osteotomies)
    30460Rhinoplasty for nasal deformity secondary to congenital cleft lip and/or palate, including columellar lengthening; tip only
    30462Rhinoplasty for nasal deformity secondary to congenital cleft lip and/or palate, including columellar lengthening; tip, septum, osteotomies
    30465Repair of nasal vestibular stenosis (e.g., spreader grafting, lateral nasal wall reconstruction)
    30468Repair of nasal valve collapse with subcutaneous/submucosal lateral wall implant(s)
    1–10 of 14
    1/2
    Prolonged, persistent nasal airway obstruction
    ThresholdNo response to 6 weeks of medical management
    Applicable managementNasal steroids, antihistamines, and decongestants may be used as medical management
    Required exclusionDrug-induced rhinitis, including rhinitis medicamentosa, must be eliminated as a cause
    Conservative management before qualifying rhinoplasty
    Minimum duration4 weeks or greater
    Examples of conservative managementNasal steroids or immunotherapy, where appropriate

    Documentation and Denial Risks

    Documentation Required

    Nasal Valve Documentation Required

    Before requesting coverage for nasal valve repair, document prolonged, persistent obstructed nasal breathing caused by internal and/or external nasal valve compromise. Show that other causes of obstruction have been adequately treated with maximal therapy, address septal deviation and turbinate hypertrophy, and provide examination, maneuver, photographic, and surgical-plan documentation.

    • Document visible collapse of the alar (lower lateral) cartilage and/or lateral nasal wall with deep inspiration.
    • Document subjective and audible improvement in airflow during the modified Cottle maneuver.
    • Include photographs showing dynamic valve collapse or an anatomical deformity narrowing the valve, consistent with the clinical examination.
    • Specify whether the compromise is static or dynamic and whether it involves the internal nasal valve, external nasal valve, or both.
    • State the surgical plan clearly, including whether a cartilage graft is needed.
    • Document that septal deviation and turbinate hypertrophy are absent, were previously treated surgically, or are scheduled for treatment during the same surgery.

    Policy Context

    The policy distinguishes reconstructive nasal surgery intended to relieve mechanical nasal airway obstruction from procedures performed primarily for cosmetic purposes. Rhinoplasty may alter nasal shape while preserving or enhancing the airway, but coverage is limited to documented functional impairment and specified clinical criteria. Adjunctive septal, nasal valve, turbinate, or sinus procedures that do not affect nasal shape or appearance are not considered rhinoplasty under the guideline.

    Clinical Definitions

    Acute Rhinosinusitis
    Core processInflammation of the mucosa of the nose and paranasal sinuses
    Typical onsetSudden onset of purulent nasal drainage
    Associated symptomsNasal obstruction, facial pain, pressure, or fullness lasting up to 4 weeks
    Chronic Rhinosinusitis
    DefinitionAn inflammatory process involving the paranasal sinuses
    DurationPersists longer than 12 weeks
    ConditionChronic rhinosinusitis
    Policy Summary
    PayerColorado Rocky Mountain Health Plans
    PolicyRhinoplasty and Other Nasal Procedures
    Policy CodePolicy SRST.MP.019.36
    Change TypeModified
    Effective DateNovember 1, 2026
    Next Review DateN/A
    Key ActionDocument the qualifying indication, examination findings, photographs, treatment plan, and required conservative-management history before submitting reconstructive rhinoplasty or nasal valve procedures.
    SourceLink
    On This Page
    Covered and Noncovered ProceduresApplicable Codes and Clinical ThresholdsDocumentation and Denial RisksPolicy ContextClinical Definitions
    The proposed procedure is designed to correct the mechanical nasal airway obstruction by centralizing the nasal bony pyramid and straightening the septum
  1. Significant symptoms: Nasal airway obstruction is causing significant symptoms, such as chronic rhinosinusitis or difficulty breathing
  2. Conservative management failure: Obstructive symptoms persist despite conservative management, including nasal steroids or immunotherapy where appropriate4 weeks or greater
  3. 4 weeks or greater
    4 weeks or greater
    Applicable procedures
    Primary, revision, and tip rhinoplasty
    Chronic rhinosinusitis
    DurationLonger than 12 weeks
    Disease processInflammatory process involving the paranasal sinuses
    Clinical categoryChronic rhinosinusitis
    Recurrent acute rhinosinusitis
    FrequencyFour episodes per year
    Episode typeAcute rhinosinusitis
    IntervalsDistinct symptom-free intervals between episodes
    Documentation Required

    Primary Rhinoplasty Documentation Required

    For primary rhinoplasty, document a qualifying reconstructive indication and demonstrate that the obstruction cannot be corrected by septoplasty alone. The record must connect the proposed procedure to correction of the mechanical obstruction and include consistent clinical and photographic findings.

    • Qualifying indications are prolonged, persistent obstructed nasal breathing from primary nasal bone and septal deviation; a severely displaced nasal fracture causing obstruction; or a residual large cutaneous defect after malignancy resection or nasal trauma.
    • Document that septoplasty alone cannot correct the obstruction.
    • Provide photographs showing nasal bone/septal deviation as the primary cause, consistent with the examination.
    • Explain that the procedure will centralize the nasal bony pyramid and straighten the septum.
    • Document significant symptoms and persistence despite at least 4 weeks of conservative management, including nasal steroids or immunotherapy when appropriate.
    Documentation Required

    Revision Rhinoplasty Documentation Required

    Revision rhinoplasty is primarily cosmetic and requires documentation of a qualifying complication or residual deformity from prior functional surgery, with persistent functional impairment. The proposed revision must address the documented mechanical obstruction and be supported by examination and photographs.

    • Document that the prior primary surgery was performed to address a functional impairment.
    • Identify the complication or residual deformity and document that functional impairment persists because of it.
    • Provide photographs showing the secondary deformity or complication as the primary cause of the mechanical nasal airway obstruction, consistent with the clinical examination.
    • Describe how the revision will correct the deformity or treat the complication and relieve the obstruction.
    • Document significant symptoms and persistence despite at least 4 weeks of conservative management, including nasal steroids or immunotherapy when appropriate.
    Documentation Required

    Tip Rhinoplasty Documentation Required

    For tip rhinoplasty, document that tip drop is the primary cause of prolonged, persistent obstructed nasal breathing. The clinical examination, photographs, and surgical plan must support correction of the resulting mechanical obstruction by lifting the nasal tip.

    • Document tip drop as the primary cause of the mechanical nasal airway obstruction.
    • Provide photographs showing tip drop, consistent with examination findings including an acute columellar-labial angle.
    • Describe that the procedure will lift the nasal tip to correct the obstruction.
    • Document significant symptoms and persistence despite at least 4 weeks of conservative management, including nasal steroids or immunotherapy when appropriate.

    Unsupported block type: documentation

    Denial Risk

    Nasal Valve Criteria Not Met

    Nasal valve procedures or repair of nasal vestibular stenosis or alar collapse are not reconstructive and medically necessary when the required valve-related obstruction, treatment history, examination, photographic, and surgical-plan criteria are absent.

    • Do not approve for indications other than qualifying internal or external nasal valve compromise causing prolonged, persistent mechanical obstruction.
    • Denial risk applies when other causes of obstruction have not received maximal treatment, or when septal deviation or turbinate hypertrophy is neither treated nor addressed in the surgical plan.
    • Denial risk applies when collapse, modified Cottle improvement, consistent photographs, valve location/type, or a clear surgical plan is not documented.
    Denial Risk

    Primary Rhinoplasty Criteria Not Met

    Primary rhinoplasty is not reconstructive and medically necessary when the qualifying indication and required documentation are absent.

    • Deny when obstruction is not primarily caused by qualifying nasal bone/septal deviation, a severely displaced obstructive nasal fracture, or a residual large cutaneous defect after malignancy resection or trauma.
    • Deny when the obstruction can be corrected by septoplasty alone, or when the proposed procedure is not designed to centralize the bony pyramid and straighten the septum.
    • Deny when photographs and examination do not establish the primary mechanical cause, symptoms are not significant, or symptoms have not persisted despite at least 4 weeks of conservative management.
    Denial Risk

    Revision Rhinoplasty Criteria Not Met

    Revision rhinoplasty is not reconstructive and medically necessary when it is not required to treat a complication or residual deformity from prior functional surgery causing persistent impairment.

    • Deny when prior surgery was not performed to address a functional impairment, or when no qualifying complication or residual deformity is documented.
    • Deny when persistent functional impairment is not attributable to the complication or deformity.
    • Deny when photographs and examination do not show the deformity or complication as the primary cause of mechanical obstruction, or when significant symptoms and 4 weeks of conservative management are not documented.
    Denial Risk

    Tip Rhinoplasty Criteria Not Met

    Tip rhinoplasty is not reconstructive and medically necessary when tip drop is not the primary cause of the mechanical nasal airway obstruction or the required supporting documentation is absent.

    • Deny when obstruction is not caused primarily by tip drop.
    • Deny when photographs and examination, including the columellar-labial angle, do not establish tip drop as the cause.
    • Deny when the procedure is not designed to lift the nasal tip and relieve obstruction, or when significant symptoms and 4 weeks of conservative management are not documented.
    Denial Risk

    Unproven Nasal Procedures

    The following nasal procedures are considered unproven and not medically necessary because of insufficient evidence of safety and/or efficacy.

    • Absorbable polylactic acid nasal cartilage support implants, including Latera, for supporting the upper or lower lateral cartilage.
    • Posterior nasal nerve or sphenopalatine ganglion ablation by any method, including radiofrequency or cryoablation, for chronic rhinitis; examples include RhinAer® and ClariFix™.
    • Radiofrequency treatment of the nasal valves for nasal airway obstruction, including the VivAer® ARC Stylus.
    Denial Risk

    Other Indications

    Reconstructive coverage for nasal valve procedures, congenital-anomaly rhinoplasty, primary rhinoplasty, revision rhinoplasty, and tip rhinoplasty is limited to the qualifying indications and criteria described in the policy. These procedures are not medically necessary for other indications.

    • Congenital-anomaly rhinoplasty is limited to nasal deformity associated with a qualifying congenital craniofacial anomaly or cleft lip or palate.
    • Nasal valve repair is limited to qualifying internal or external valve compromise with persistent mechanical obstruction and the required treatment, examination, photographic, and surgical-plan documentation.
    • Primary rhinoplasty is limited to qualifying obstructive nasal deformity, severe displaced fracture, or residual large cutaneous defect; revision rhinoplasty requires a complication or residual deformity from prior functional surgery; tip rhinoplasty requires tip drop as the primary cause of obstruction.
    • Cosmetic, nonqualifying, or otherwise undocumented indications are not reconstructive and not medically necessary.
    Denial Risk

    Absorbable Nasal Cartilage Support Implants

    Absorbable nasal cartilage support implants, posterior nasal nerve or sphenopalatine ganglion ablation, and radiofrequency nasal valve treatment remain unproven and not medically necessary under this policy, regardless of regulatory status or device marketing.

    • Examples include Latera, RhinAer®, ClariFix™, and VivAer® ARC Stylus.
    Denial Risk

    Posterior Nasal Nerve or Sphenopalatine Ganglion Ablation

    Posterior nasal nerve or sphenopalatine ganglion ablation is considered unproven and not medically necessary for chronic rhinitis when performed by any method.

    • Includes radiofrequency ablation and cryoablation.
    • Examples include RhinAer® and ClariFix™.
    Denial Risk

    Radiofrequency Nasal Valve Treatment

    Radiofrequency treatment of the nasal valves for nasal airway obstruction is considered unproven and not medically necessary.

    • Includes the VivAer® ARC Stylus.
    Note

    FDA Clearance Does Not Establish Coverage

    FDA approval or clearance alone does not establish coverage under this policy. Coverage depends on the policy's medical-necessity and reconstructive criteria, regardless of a device's regulatory status.

    • The FDA classifies rhinoplasty and other sinus-surgery devices under broad product code LRC, and some devices may be 510(k) exempt.
    • The VivAer Stylus received 510(k) clearance in March 2020, but that clearance alone is not a basis for coverage.
    External Nasal Valve
    Anatomic locationThe entrance to the nose
    Included structuresCaudal edge of the lateral crus of the lower lateral cartilage, soft tissue alae, membranous septum, and nostril sill
    Valve typeExternal nasal valve
    Functional or Physical or Physiological Impairment
    Core definitionDeviation from the normal function of a tissue or organ
    Functional effectSignificantly limited, impaired, or delayed capacity to move, coordinate actions, or perform physical activities
    Affected areasPhysical and motor tasks, independent movement, or basic life functions
    Mechanical Nasal Airway Obstruction
    Primary symptomTrouble breathing through the nose, not snoring
    CauseA bony or cartilaginous deformity
    ConditionMechanical nasal airway obstruction
    Prolonged, Persistent Nasal Airway Obstruction
    Primary symptomTrouble breathing through the nose, not snoring
    Treatment thresholdNo response to 6 weeks of medical management
    Examples of managementNasal steroids, antihistamines, and decongestants
    Recurrent Acute Rhinosinusitis
    FrequencyFour episodes of acute rhinosinusitis per year
    Interval requirementDistinct symptom-free intervals between episodes
    ConditionRecurrent acute rhinosinusitis
    Rhinitis Medicamentosa
    MechanismRebound nasal congestion
    CauseExtended use of topical nasal decongestants
    ExamplesOxymetazoline, phenylephrine, xylometazoline, or naphazoline nasal sprays
    Rhinoplasty
    ProcedureSurgical alteration of the shape or appearance of the nose
    Airway objectivePreserves or enhances the nasal airway
    Potential purposeMay address a functional abnormality or be performed for cosmetic purposes
    Nasal valve repair
    Procedure typeA distinct surgical procedure
    PurposeImprove nasal obstruction symptoms
    IndicationAppropriately selected patients with nasal valve collapse
    Adjunctive nasal procedures
    Anatomic scopeNasal septum, nasal valve, turbinates, or paranasal sinuses
    Structural effectPerformed without affecting nasal shape or appearance
    ClassificationDoes not meet the policy definition of rhinoplasty
    PNN ablation
    TargetPosterior nasal nerve
    Treatment methodsCryotherapy or transmucosal radiofrequency
    Intended effectReduce chronic rhinitis symptoms
    Nasal airway obstruction due to nasal valve collapse
    ConditionNasal airway obstruction
    Associated anatomyCollapse or dysfunction of the nasal valve region
    AbbreviationNAO due to nasal valve collapse
    TCRF treatment
    Treatment typeTransmucosal radiofrequency treatment
    Treatment regionNasal valve region
    Example systemVivAer system